This page includes the latest FDA filings for Blueprint Medicines Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | BPMC | DUNS 021905363 |
Device Company | Device | Date |
---|---|---|
Blueprint Medicines Corporation | Prescription Medication | 2024-05-17 |
Blueprint Medicines Corporation | Prescription Medication | 2024-04-12 |
Blueprint Medicines Corporation | Prescription Medication | 2023-05-28 |
Blueprint Medicines Corporation | Prescription Medication | 2023-03-18 |
Blueprint Medicines Corporation | Prescription Medication | 2023-02-08 |
Blueprint Medicines Corporation | Prescription Medication | 2021-10-20 |
Blueprint Medicines Corporation | Prescription Medication | 2021-06-23 |
Blueprint Medicines Corporation | Prescription Medication | 2021-05-22 |
Blueprint Medicines Corporation | Prescription Medication | 2021-01-14 |
Blueprint Medicines Corporation | Prescription Medication | 2020-09-11 |
Blueprint Medicines Corporation | GAVRETO | 2020-09-04 |
Blueprint Medicines Corporation | Prescription Medication | 2020-01-22 |
Blueprint Medicines Corporation | Ayvakit | 2020-01-09 |
Blueprint Medicines Corporation | Ayvakit | 2020-01-09 |
Blueprint Medicines Corporation | Ayvakit | 2020-01-09 |
Blueprint Medicines Corporation | Ayvakit | 2020-01-09 |
Blueprint Medicines Corporation | Ayvakit | 2020-01-09 |
NCAGE Code | 6NX60 | BLUEPRINT MEDICINES CORPORATION!DBA BLUEPRINT MEDICINES |
CAGE Code | 6NX60 | BLUEPRINT MEDICINES CORPORATION |
S.A.M. Registration | 6NX60 [21905363] | BLUEPRINT MEDICINES CORPORATION |
SEC | 0001597264 | Blueprint Medicines Corp of DELAWARE |